Menu

• Ask a Health Expert about APPLICATION SITE VESICLES
• Post Your Side Effect related to APPLICATION SITE VESICLES
• APPLICATION SITE VESICLES and FDA Warnings
• APPLICATION SITE VESICLES in Patients Wiki
• Report APPLICATION SITE VESICLES in Drug Side Effect Survey

APPLICATION SITE VESICLES side effect

What is APPLICATION SITE VESICLES ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Fentanyl Side Effects Report #5648934-4
Consumer or non-health professional from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Feb 22, 2008. Male patient, weighting 220.0 lb, was diagnosed with pain, hypertension and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site vesicles, back pain, spinal fusion surgery, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with LORTAB, LISINOPRIL, DOXAZOSIN MESYLATE. Patient was hospitalized. Patient recovered.

Duragesic Side Effects Report #5669544-9
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2008. Female patient, weighting 190.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site vesicles, latex allergy, surgery, treatment noncompliance, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM. Patient was hospitalized. Patient recovered.

Nitro Side Effects Report #5689753-2
Physician from ITALY reported NITRO problem on Mar 19, 2008. Female patient, 96 years of age, was diagnosed with ischaemia and was treated with NITRO. After drug was administered, patient experienced the following problems/side effects: application site vesicles, arrhythmia, cardio-respiratory arrest, . NITRO dosage: unknown. During the same period patient was treated with TAVOR, DEURSIL, LASIX, TIENAM, ANTRA. Patient was hospitalized. Patient died on 02/08/2008.

Climara Side Effects Report #5610146-8
CLIMARA PRO problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 11, 2007. Female patient, 46 years of age, was treated with CLIMARA PRO. After drug was administered, patient experienced the following problems/side effects: application site vesicles, . CLIMARA PRO dosage: unknown. Patient recovered.


Neupro Side Effects Report #5587827-8
Consumer or non-health professional from UNITED STATES reported NEUPRO problem on Aug 21, 2007. Female patient was diagnosed with parkinson's disease and was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site vesicles, rash erythematous, rash pruritic, . NEUPRO dosage: 6MG/24H,1 IN 1 D,TRANSDERMAL. During the same period patient was treated with ZELAPAR, STALEVO, NAMENDA, SYNTHROID, EVISTA, GALANTAMINE HYDROBROMIDE, FORTEO, GINGER CANDY. Patient recovered.

Altabax Side Effects Report #5511334-1
ALTABAX problem was reported by a Health Professional from UNITED STATES on Sept 27, 2007. Female patient, 54 years of age, was treated with ALTABAX. After drug was administered, patient experienced the following problems/side effects: application site vesicles, blister, . ALTABAX dosage: unknown. During the same period patient was treated with ATACAND HCT, PREMARIN, ZOLOFT. Patient recovered.

Fentanyl Side Effects Report #5502624-7
Physician from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Oct 22, 2007. Female patient, weighting 105.0 lb, was diagnosed with phantom pain and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site vesicles, decubitus ulcer, osteoporotic fracture, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

Abreva Side Effects Report #5462401-2
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Female patient, 88 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site vesicles, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462695-3
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Feb 23, 2007. Female patient, 82 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site vesicles, . ABREVA dosage: unknown. Patient recovered.


Banana Side Effects Report #5501417-4
BANANA BOAT SPF problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 28, 2007. Female patient, 54 years of age, weighting 120.0 lb, was diagnosed with tanning and was treated with BANANA BOAT SPF. After drug was administered, patient experienced the following problems/side effects: application site vesicles, photosensitivity reaction, skin exfoliation, . BANANA BOAT SPF dosage: unknown. During the same period patient was treated with SOLARCANE, BENADRYL CREAM, CLARITIN. Patient recovered.

Fentanyl Side Effects Report #5422534-3
Consumer or non-health professional from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Aug 14, 2007. Female patient, weighting 105.0 lb, was diagnosed with phantom pain and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site vesicles, decubitus ulcer, osteoporotic fracture, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

Duragesic Side Effects Report #5423374-1
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2007. Male patient, weighting 220.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site vesicles, arthritis, inadequate analgesia, poor quality sleep, . DURAGESIC dosage: unknown. Patient recovered.

Catapres Side Effects Report #5428141-0
Pharmacist from UNITED STATES reported CATAPRES problem on June 21, 2007. Male patient, child 2 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with CATAPRES. After drug was administered, patient experienced the following problems/side effects: application site vesicles, . CATAPRES dosage: unknown. Patient recovered.

Duragesic Side Effects Report #5762277-X
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2008. Female patient, weighting 125.0 lb, was diagnosed with pain, pain in extremity, anxiety and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site vesicles, blood cholesterol increased, cardiac valve disease, dermatitis contact, hypertension, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, FENTANYL TRANSDERMAL SYSTEM, ULTRAM, XANAX. Patient recovered.


Climara Side Effects Report #5763527-6
Consumer or non-health professional from UNITED STATES reported CLIMARA problem on May 19, 2008. Female patient, 81 years of age, weighting 149.9 lb, was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site vesicles, cardiac disorder, lymphoma, . CLIMARA dosage: unknown. Patient recovered.

Duragesic Side Effects Report #5780115-6
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on June 10, 2008. Female patient, weighting 125.0 lb, was diagnosed with pain, pain in extremity, anxiety and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site vesicles, blood cholesterol increased, cardiac valve disease, dermatitis contact, hypertension, skin disorder, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, FENTANYL TRANSDERMAL SYSTEM, ULTRAM, XANAX. Patient recovered.

Climara Side Effects Report #5782790-9
Consumer or non-health professional from UNITED STATES reported CLIMARA problem on Feb 26, 2008. Female patient, 68 years of age, weighting 130.1 lb, was diagnosed with menopausal symptoms and was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site vesicles, rash, . CLIMARA dosage: unknown. During the same period patient was treated with ATENOLOL, HYDROCHLOROTHIAZIDE. Patient recovered.

Duragesic Side Effects Report #5725479-4
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 21, 2008. Female patient, weighting 125.0 lb, was diagnosed with pain in extremity, anxiety and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site vesicles, blood cholesterol increased, cardiac valve disease, hypertension, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, ULTRAM, XANAX. Patient recovered.

Neupro Side Effects Report #5732032-5
Consumer or non-health professional from GERMANY reported NEUPRO problem on Apr 07, 2008. Male patient, 65 years of age, was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site vesicles, dry skin, erythema, impaired healing, pruritus, scar, skin exfoliation, . NEUPRO dosage: 4 MG/24H (24 MG/24H 1 IN 1 DAY(S)). Patient recovered.


Desenex Side Effects Report #5735943-X
DESENEX PRESCRIPTIONSTRENGTH SPRAYLIQUID problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 28, 2008. Male patient, 42 years of age, was diagnosed with tinea pedis and was treated with DESENEX PRESCRIPTIONSTRENGTH SPRAYLIQUID. After drug was administered, patient experienced the following problems/side effects: application site vesicles, burns second degree, . DESENEX PRESCRIPTIONSTRENGTH SPRAYLIQUID dosage: unknown. Patient recovered.

Climara Side Effects Report #5753407-4
Consumer or non-health professional from UNITED STATES reported CLIMARA problem on May 19, 2008. Female patient, 81 years of age, weighting 149.9 lb, was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site vesicles, cardiac disorder, lymphoma, . CLIMARA dosage: unknown. Patient recovered.

Climara Side Effects Report #5698466-2
CLIMARA problem was reported by a Consumer or non-health professional from UNITED STATES on June 16, 2006. Female patient, 49 years of age, weighting 127.9 lb, was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site vesicles, . CLIMARA dosage: unknown. Patient recovered.

Climara Side Effects Report #5698667-3
Consumer or non-health professional from UNITED STATES reported CLIMARA problem on Jan 17, 2007. Female patient, 43 years of age, weighting 141.1 lb, was diagnosed with menopausal symptoms prophylaxis and was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site vesicles, . CLIMARA dosage: unknown. Patient recovered.

Oxytrol Side Effects Report #5318060-2
OXYTROL problem was reported by a Pharmacist from UNITED STATES on May 04, 2007. Female patient, 55 years of age, was treated with OXYTROL. After drug was administered, patient experienced the following problems/side effects: application site vesicles, incorrect dose administered, wound secretion, . OXYTROL dosage: unknown. Patient recovered.

Duragesic Side Effects Report #5674588-7
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on Mar 11, 2008. Female patient, weighting 130.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: anxiety, application site vesicles, dermatitis contact, haemorrhage, insomnia, nerve injury, neuralgia, pain in extremity, . DURAGESIC dosage: unknown. Patient recovered.

Duragesic Side Effects Report #5619783-8
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2008. Female patient, weighting 300.0 lb, was diagnosed with pain, nausea, epilepsy and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site irritation, application site vesicles, withdrawal syndrome, . DURAGESIC dosage: unknown. During the same period patient was treated with PHENERGAN, TOPAMAX. Patient recovered.

Pain Side Effects Report #5627198-1
Health Professional from UNITED STATES reported PAIN PATCH BACK ASPERCREME problem on Feb 12, 2008. Female patient, weighting 170.0 lb, was diagnosed with back pain and was treated with PAIN PATCH BACK ASPERCREME. After drug was administered, patient experienced the following problems/side effects: application site burn, application site vesicles, pain, . PAIN PATCH BACK ASPERCREME dosage: unknown. Patient recovered.

Duragesic Side Effects Report #5608961-X
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 22, 2008. Female patient, weighting 130.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: anxiety, application site vesicles, haemorrhage, insomnia, nerve injury, neuralgia, pain in extremity, skin lesion, . DURAGESIC dosage: unknown. Patient recovered.

Duragesic Side Effects Report #5490576-8
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on Oct 10, 2007. Female patient, weighting 220.0 lb, was diagnosed with rheumatoid arthritis and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site rash, application site vesicles, oedema peripheral, thrombosis, . DURAGESIC dosage: unknown. Patient was hospitalized. Patient recovered.

Abreva Side Effects Report #5461471-5
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 19, 2006. Female patient, 56 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site vesicles, oral herpes, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462743-0
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Mar 05, 2007. Female patient, 52 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site reaction, application site vesicles, lip swelling, . ABREVA dosage: unknown. Patient recovered.

Myozyme Side Effects Report #5474472-8
MYOZYME problem was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Sept 13, 2007. Male patient, child 3 years of age, weighting 32.85 lb, was diagnosed with glycogen storage disease type ii and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, application site vesicles, aspartate aminotransferase increased, bedridden, blood lactate dehydrogenase increased, bone density decreased, diarrhoea, eczema, gastroenteritis rotavirus, . MYOZYME dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA, AMBROXOL, CARDIOLOL, ISOMIL, BIOCAL. Patient was hospitalized and became disabled. Patient recovered.

Estradiol Side Effects Report #5413206-X
Pharmacist from AUSTRALIA reported ESTRADIOL problem on Aug 10, 2007. Female patient was treated with ESTRADIOL. After drug was administered, patient experienced the following problems/side effects: application site irritation, application site vesicles, . ESTRADIOL dosage: unknown. During the same period patient was treated with IRBESARTAN, NORMISON, ATORVASTATIN CALCIUM. Patient recovered.

Estraderm Side Effects Report #5420478-4
ESTRADERM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 16, 2007. Female patient, 49 years of age, was diagnosed with menopause and was treated with ESTRADERM. After drug was administered, patient experienced the following problems/side effects: application site scar, application site vesicles, urticaria, . ESTRADERM dosage: 50MG DAILY. Patient recovered.

Nicoderm Side Effects Report #5426269-2
Consumer or non-health professional from UNITED STATES reported NICODERM CQ problem on Aug 22, 2007. Female patient, 49 years of age, was treated with NICODERM CQ. After drug was administered, patient experienced the following problems/side effects: application site irritation, application site vesicles, cardiac arrest, . NICODERM CQ dosage: unknown. Patient recovered.

Daytrana Side Effects Report #5452085-1
DAYTRANA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 09, 2007. Male patient, child 10 years of age, weighting 84.88 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site vesicles, urticaria, . DAYTRANA dosage: 10 MG, TRANSDERMAL. Patient recovered.

Estraderm Side Effects Report #5381630-X
Pharmacist from UNITED KINGDOM reported ESTRADERM problem on June 28, 2007. Female patient, 49 years of age, was diagnosed with menopause and was treated with ESTRADERM. After drug was administered, patient experienced the following problems/side effects: application site scar, application site vesicles, urticaria, . ESTRADERM dosage: 50MG DAILY. Patient recovered.

Estraderm Side Effects Report #5388960-6
ESTRADERM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 10, 2007. Female patient, 49 years of age, was diagnosed with menopause and was treated with ESTRADERM. After drug was administered, patient experienced the following problems/side effects: application site scar, application site vesicles, urticaria, . ESTRADERM dosage: 50MG DAILY. Patient recovered.

Estraderm Side Effects Report #5381630-X
Pharmacist from UNITED KINGDOM reported ESTRADERM problem on June 28, 2007. Female patient, 49 years of age, was diagnosed with menopause and was treated with ESTRADERM. After drug was administered, patient experienced the following problems/side effects: application site scar, application site vesicles, urticaria, . ESTRADERM dosage: 50MG DAILY. Patient recovered.

Estraderm Side Effects Report #5388960-6
ESTRADERM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 10, 2007. Female patient, 49 years of age, was diagnosed with menopause and was treated with ESTRADERM. After drug was administered, patient experienced the following problems/side effects: application site scar, application site vesicles, urticaria, . ESTRADERM dosage: 50MG DAILY. Patient recovered.

Catapres Side Effects Report #5760180-2
Consumer or non-health professional from UNITED STATES reported CATAPRES problem on May 08, 2008. Male patient, 60 years of age, was diagnosed with hypertension and was treated with CATAPRES. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site vesicles, . CATAPRES dosage: unknown. During the same period patient was treated with TOPROL, SPIRONOLACTONE, ZETIA, ASPIRIN. Patient recovered.

Climara Side Effects Report #5760737-9
CLIMARA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 01, 2008. Female patient, 57 years of age, weighting 130.1 lb, was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site burn, application site vesicles, . CLIMARA dosage: unknown. During the same period patient was treated with ARMOUR. Patient recovered.

Neupro Side Effects Report #5766067-3
Consumer or non-health professional from UNITED STATES reported NEUPRO problem on Apr 18, 2008. Male patient, 57 years of age, was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site reaction, application site vesicles, . NEUPRO dosage: MG/24H, 1 IN 1 D, TRANSDERMAL. Patient recovered.

Climara Side Effects Report #5786949-6
CLIMARA problem was reported by a Pharmacist from UNITED STATES on Mar 31, 2008. Female patient, 55 years of age, was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site rash, application site vesicles, . CLIMARA dosage: unknown. Patient recovered.

Desenex Side Effects Report #5741092-7
Consumer or non-health professional from UNITED STATES reported DESENEX PRESCRIPTION STRENGTH SPRAY LIQUID SPRAY problem on May 07, 2008. Male patient, 42 years of age, was diagnosed with tinea pedis and was treated with DESENEX PRESCRIPTION STRENGTH SPRAY LIQUID SPRAY. After drug was administered, patient experienced the following problems/side effects: application site burn, application site vesicles, burns second degree, . DESENEX PRESCRIPTION STRENGTH SPRAY LIQUID SPRAY dosage: unknown. Patient recovered.

Estradiol Side Effects Report #5745103-4
ESTRADIOL problem was reported by a Pharmacist from AUSTRALIA on May 17, 2008. Female patient was treated with ESTRADIOL. After drug was administered, patient experienced the following problems/side effects: application site irritation, application site vesicles, . ESTRADIOL dosage: unknown. During the same period patient was treated with IRBESARTAN, NORMISON, ATORVASTATIN CALCIUM. Patient recovered.

Daytrana Side Effects Report #5366058-0
Physician from UNITED STATES reported DAYTRANA problem on Dec 21, 2006. Male patient was diagnosed with psychomotor hyperactivity and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site dermatitis, application site vesicles, . DAYTRANA dosage: 20 MG EVERY MORNING, TRANSDERMAL. Patient recovered.

Fentanyl Side Effects Report #5339822-1
FENTANYL TRANSDERMAL SYSTEM problem was reported by a Physician from UNITED STATES on May 21, 2007. Female patient, weighting 138.0 lb, was diagnosed with pain, back pain, depression, multiple allergies, asthma, laxative supportive care and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site pain, application site vesicles, migraine, spinal disorder, therapeutic response decreased, weight decreased, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with DURAGESIC, PERCOCET, PAXIL CR, ALLEGRA, SINGULAIR, ADVAIR DISKUS, ALBUTEROL, GLYCOLAX. Patient recovered.

Nicotine Side Effects Report #5343598-1
Consumer or non-health professional from UNITED KINGDOM reported NICOTINE problem on May 17, 2007. Female patient, 58 years of age, was treated with NICOTINE. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site vesicles, blister, joint swelling, pain, pruritus, weight increased, . NICOTINE dosage: 21 MG, QD, TRANSDERMAL. During the same period patient was treated with PREMARIN, REMEDEINE. Patient recovered.

Duragesic Side Effects Report #5284146-4
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2007. Female patient, weighting 151.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site necrosis, application site vesicles, deafness, dermatitis contact, gallbladder disorder, laryngitis, liver disorder, . DURAGESIC dosage: unknown. Patient was hospitalized. Patient recovered.

Fentanyl Side Effects Report #5256091-1
Consumer or non-health professional from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Feb 26, 2007. Female patient, weighting 125.0 lb, was diagnosed with pain, back pain, depression, multiple allergies, asthma, laxative supportive care and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site pain, application site vesicles, migraine, spinal disorder, therapeutic response decreased, weight decreased, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with DURAGESIC, PERCOCET, PAXIL CR, ALLEGRA, ADVAIR DISKUS, ALBUTEROL, GLYCOLAX. Patient recovered.